Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

KEVIN TIN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1174812044
CMS profile
1382257
Location
BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$19,668.52

88 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 2; records 51–88 of 88 matching records. This page contains 38 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

KEVIN TIN

NPI 1174812044 · CMS profile ID 1382257

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

BROOKLYN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–88 of 88 matching records. This page contains 38 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1174812044?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
KEVIN TIN, NPI 1174812044, CMS profile ID 1382257. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–88 of 88 matching records. This page contains 38 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1174812044?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). KEVIN TIN, NPI 1174812044, CMS profile ID 1382257. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–88 of 88 matching records. This page contains 38 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1174812044?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
KEVIN TIN, NPI 1174812044, CMS profile ID 1382257, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–88 of 88 matching records. This page contains 38 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1174812044?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

88 matching records · $19,668.52 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 88 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–88 of 88.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.0406/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057361947 CMS
Gilead Sciences, Inc. $2,830.0006/23/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035834389 CMS
Gilead Sciences, Inc. $125.0006/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025506135 CMS
AIMMUNE THERAPEUTICS, INC. $19.2506/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 998920285 CMS
IBSA Pharma Inc. $17.6806/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999763439 CMS
IBSA Pharma Inc. $7.0006/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999763447 CMS
Gilead Sciences, Inc. $21.6805/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025757167 CMS
AbbVie Inc. $19.1305/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266585 CMS
Gilead Sciences, Inc. $24.3305/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025661609 CMS
Gilead Sciences, Inc. $116.6705/16/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025516995 CMS
AbbVie Inc. $24.5105/12/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266581 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.1505/09/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057304437 CMS
NESTLE HEALTHCARE NUTRITION INC. $15.9405/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012432349 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.2005/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057185249 CMS
Janssen Biotech, Inc. $35.4105/02/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 988287405 CMS
Gilead Sciences, Inc. $13.3204/28/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025494737 CMS
Gilead Sciences, Inc. $45.7804/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025535765 CMS
Gilead Sciences, Inc. $33.0404/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025547711 CMS
Gilead Sciences, Inc. $19.3704/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025838917 CMS
Gilead Sciences, Inc. $3,710.0004/28/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035834383 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.1304/27/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057192397 CMS
Intra-Sana Laboratories $14.5904/26/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057052039 CMS
AbbVie Inc. $23.3404/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266577 CMS
AbbVie Inc. $28.7404/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266573 CMS
IBSA Pharma Inc. $125.0004/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999763463 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.0004/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057389459 CMS
Gilead Sciences, Inc. $2,830.0004/05/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035834377 CMS
AbbVie Inc. $1,875.0004/04/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266569 CMS
Gilead Sciences, Inc. $20.0004/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025816607 CMS
AbbVie Inc. $150.0003/30/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266565 CMS
Gilead Sciences, Inc. $16.1603/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025957819 CMS
Gilead Sciences, Inc. $19.1703/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1025846551 CMS
AbbVie Inc. $23.5803/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 999266561 CMS
Gilead Sciences, Inc. $9.1203/10/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026078869 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.3403/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057216905 CMS
Gilead Sciences, Inc. $8.0401/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026088629 CMS
Gilead Sciences, Inc. $9.4001/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1026076371 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.8801/05/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1057134045 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $862.06 50
PY2020 $8,262.25 56
PY2021 $31,612.99 109
PY2022 $8,619.12 65
PY2023 $19,668.52 88
PY2024 $45,783.94 163
PY2025 $52,991.33 164

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $175,629.15 5
PY2024 Principal investigator $25,562.00 2

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $18,587.91 10/10/2025 Non-covered Recipient Entity
MEDTRAITS NY LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223286717
Principal investigator 1 Novartis Pharmaceuticals Corporation $89.47 08/08/2025 Non-covered Recipient Entity
WCG MEDTRIATS NY
A Phase III, Multicenter, Randomized, Placebo Controlled, Double-blind Study to Assess Efficacy and Safety of Crizanlizumab (5 mg/kg) Versus Placebo, With or Without Hydroxyurea/Hydroxycarbamide Therapy, in Adolescent and Adult Sickle Cell Disease Patient No dispute reported 06/30/2026 1190312847
Principal investigator 1 Takeda Pharmaceuticals U.S.A., Inc. $1,199.22 05/02/2025 Non-covered Recipient Entity
MEDTRAITS NY LLC
ENTYVIO (VEDOLIZUMAB) LONG-TERM SAFETY STUDY: AN INTERNATIONAL OBSERVATIONAL PROSPECTIVE COHORT STUDY COMPARING VEDOLIZUMAB TO OTHER BIOLOGIC AGENTS IN PATIENTS WITH ULCERATIVE COLITIS OR CROHN'S DISEASE No dispute reported 06/30/2026 1223278930
Principal investigator 1 AstraZeneca Pharmaceuticals LP $88,918.10 03/19/2025 Non-covered Recipient Entity
MEDTRAITS NY
A Phase 2 randomized double blind placebo controlled dose regimen range finding study to assess efficacy and safety of subcutaneous tozorakimab in adult participants with uncontrolled asthma on medium to high dose inhaled corticosteroids No dispute reported 06/30/2026 1185537263
Principal investigator 1 AstraZeneca Pharmaceuticals LP $66,834.45 01/17/2025 Non-covered Recipient Entity
MEDTRAITS NY
A Phase 4 Multicenter Randomized Double blind Parallel Group Placebo controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics (CHINOOK) No dispute reported 06/30/2026 1185537261